HomeWebcastPatent Protection for Pharma and Biotechnology in 2020
Online CLE Patent Protection CLE

Patent Protection for Pharma and Biotechnology in 2020

Live Webcast Date: Wednesday, April 01, 2020 from 12:00 pm to 2:00 pm (ET)
Intellectual Property CLE & CPEPharmaceutical & Life Sciences CLE & CPELive Webcast
Registration & Pricing Options
Add to Calendar 04/01/2020 12:00 pm 04/01/2020 2:00 pm America/New_York The Knowledge Group Webinar: Patent Protection for Pharma and Biotechnology in 2020 If you haven’t registered for this event please click here:https://www.theknowledgegroup.org/checkout/?add-to-cart=143143\r\n Pharmaceutical and biotechnology patents have increased aggressively in recent years. Consequently, this upward trend has posed a greater risk for the U.S. pharma patents. Political and economic troubles such as claims of patent evergreening abuse have also added complexity on existing challenges. \n \nAs biopharma innovators face this troubled landscape, effective IP protection strategies have become more imperative. Current and future plans must be carefully weaved to properly address legal challenges. \n \nIn this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the fundamentals as well as recent developments in pharma and biotechnology patent. Speakers will also present helpful tips on how companies and patent owners can strengthen their strategies to overcome significant hurdles. \n \nKey topics include: \n \n \n Trends and Developments in U.S. Pharma and Biotechnology Patents \n Current and Emerging Challenges Faced by Patent Owners \n Notable Cases \n Best Practices and Helpful Tips \n Outlook \n \n https://www.theknowledgegroup.org/webcasts/pharma-and-biotechnology-in-2020/

Online CLE Patent Protection

Join us for this Knowledge Group Online CLE Patent Protection Webinar. Pharmaceutical and biotechnology patents have increased aggressively in recent years. Consequently, this upward trend has posed a greater risk for the U.S. pharma patents. Political and economic troubles such as claims of patent evergreening abuse have also added complexity on existing challenges.

As biopharma innovators face this troubled landscape, effective IP protection strategies have become more imperative. Current and future plans must be carefully weaved to properly address legal challenges.

In this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the fundamentals as well as recent developments in pharma and biotechnology patent. Speakers will also present helpful tips on how companies and patent owners can strengthen their strategies to overcome significant hurdles.

Key topics include:

  • Trends and Developments in U.S. Pharma and Biotechnology Patents
  • Current and Emerging Challenges Faced by Patent Owners
  • Notable Cases
  • Best Practices and Helpful Tips
  • Outlook

Agenda

Fernando Muzzio, Principal Consultant
Acumen BioPharma, LLC

Brian M. Gummow, Counsel
Haley Guiliano LLP

Who Should Attend

  • Patent Attorneys and Consultants
  • Biotech/Pharma Industry Lawyers
  • In-House Counsel for Pharma/Biotech & Drug Manufacturing Companies
  • Patent Portfolio Managers
  • Heads of Patent and IP
  • Executives coming from Biotech and Pharmaceutical Firms

Online CLE Patent Protection

Fernando Muzzio, Principal Consultant
Acumen BioPharma, LLC

Brian M. Gummow, Counsel
Haley Guiliano LLP

Online CLE Patent Protection

Online CLE Patent Protection

Fernando MuzzioPrincipal ConsultantAcumen BioPharma, LLC

Dr. Fernando J. Muzzio is a distinguished Professor of Chemical and Biochemical Engineering at Rutgers University. For the last 28 years, pharmaceutical product and process design has been his main research and educational focus, with emphasis on continuous manufacturing, powder mixing, powder flow, segregation, compression, mixing and flow of liquids and suspensions, capsule filling, tablet dissolution, and tablet coating. He is the author of over 300 peer-reviewed scientific articles and book chapters. He is a frequent participant at FDA events, and in 2010-2014 he was appointed a voting member of the FDA committee on Pharmaceutical Sciences and clinical pharmacology.

Fernando Muzzio is the director of the National Science Foundation Engineering Research Center on Structured Organic Particulate Systems. The center focuses on pharmaceutical product and process design, with special emphasis on continuous manufacturing, particle engineering, and personalized medicine.  Dr. Muzzio is also the director of the Rutgers/Janssen partnership in Advanced Manufacturing and the Principal Investigator of a major FDA research award focused on material properties, sensing, and process control in Continuous Manufacturing.

Professor Muzzio is also the president of Integra Continuous Manufacturing Systems, a supplier of comprehensive consulting services in continuous manufacturing, ( www.integracms-pharma.com) and the Chief Scientific Officer of Acumen Biopharma.  Acumen Biopharma is a specialty consulting firm providing comprehensive expert witness and testing services in intellectual property and anti-trust litigation cases in the pharmaceutical industry. For additional information, go to acumenbiopharma.com

Dr. Muzzio has been an expert witness in numerous IP litigation cases, with a special focus on formulation and manufacturing processes for solid dose, inhalable, and suspension products.

Online CLE Patent Protection

Brian M. GummowCounselHaley Guiliano LLP

Brian M. Gummow is currently a Counsel at Haley Guiliano LLP. For more than a decade, Brian has been counseling clients in the biotechnology, pharmaceutical, medical device, food processing, and consumer products industries on a variety of intellectual property issues, including patent portfolio development, patent prosecution, freedom-to-operate opinions, invalidity opinions, patentability opinions, patent interferences, post-grant challenges in the U.S. and around the world, and patent infringement litigations. He works with clients to develop strategies for obtaining and managing robust and enforceable patent protection in the United States and around the world. He also helps clients evaluate the competitive patent landscape and develop strategies to operate their business in view of competitors’ patents.


Click Here to Read Additional Material

Online CLE Patent Protection

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   Live Webcast

Prerequisite:
   General knowledge patent/life sciences law

Course Code:
   148447

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    2.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Acumen BioPharma  provides expert witness  consulting and laboratory services to law firms engaged in intellectual property and antitrust litigation related to the pharmaceutical industry. Our expertise includes all aspects of manufacturing technology, regulatory, supply chain and commercial operations involved for branded and generics pharmaceuticals and biopharmaceutical products. Acumen BioPharma’s subsidiary registered as Integra Continuous Manufacturing Systems (www.integracms-pharma.com) is dedicated to consulting services in advance manufacturing technology to assist clients in the design and implementation of continuous manufacturing lines for pharmaceutical products.

Website: http://www.acumenbiopharma.com/

Haley Guiliano LLP is dedicated to helping its clients resolve high-stakes intellectual property law challenges through a wide-ranging global practice.  Our attorneys, patent agents, and technical advisors are leading professionals who have handled some of the largest and most influential intellectual property matters in the IP arena in recent years.  We combine sophisticated legal and technical backgrounds with an in-depth understanding of complex business needs to provide our clients with individualized solutions that protect and advance their IP interests.

Website: https://www.hglaw.com/

Dr. Fernando J. Muzzio is a distinguished Professor of Chemical and Biochemical Engineering at Rutgers University. For the last 28 years, pharmaceutical product and process design has been his main research and educational focus, with emphasis on continuous manufacturing, powder mixing, powder flow, segregation, compression, mixing and flow of liquids and suspensions, capsule filling, tablet dissolution, and tablet coating. He is the author of over 300 peer-reviewed scientific articles and book chapters. He is a frequent participant at FDA events, and in 2010-2014 he was appointed a voting member of the FDA committee on Pharmaceutical Sciences and clinical pharmacology.

Fernando Muzzio is the director of the National Science Foundation Engineering Research Center on Structured Organic Particulate Systems. The center focuses on pharmaceutical product and process design, with special emphasis on continuous manufacturing, particle engineering, and personalized medicine.  Dr. Muzzio is also the director of the Rutgers/Janssen partnership in Advanced Manufacturing and the Principal Investigator of a major FDA research award focused on material properties, sensing, and process control in Continuous Manufacturing.

Professor Muzzio is also the president of Integra Continuous Manufacturing Systems, a supplier of comprehensive consulting services in continuous manufacturing, ( www.integracms-pharma.com) and the Chief Scientific Officer of Acumen Biopharma.  Acumen Biopharma is a specialty consulting firm providing comprehensive expert witness and testing services in intellectual property and anti-trust litigation cases in the pharmaceutical industry. For additional information, go to acumenbiopharma.com

Dr. Muzzio has been an expert witness in numerous IP litigation cases, with a special focus on formulation and manufacturing processes for solid dose, inhalable, and suspension products.

Brian M. Gummow is currently a Counsel at Haley Guiliano LLP. For more than a decade, Brian has been counseling clients in the biotechnology, pharmaceutical, medical device, food processing, and consumer products industries on a variety of intellectual property issues, including patent portfolio development, patent prosecution, freedom-to-operate opinions, invalidity opinions, patentability opinions, patent interferences, post-grant challenges in the U.S. and around the world, and patent infringement litigations. He works with clients to develop strategies for obtaining and managing robust and enforceable patent protection in the United States and around the world. He also helps clients evaluate the competitive patent landscape and develop strategies to operate their business in view of competitors’ patents.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199